124 results on '"Bouchaab, Hasna"'
Search Results
2. 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.
3. A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial
4. Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update.
5. Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis
6. Stereotactic lung reirradiation for local relapse: A case series
7. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
8. Prise en charge des métastases osseuses du cancer pulmonaire non à petites cellules
9. Oncologie: ce qui a changé en 2023
10. Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort
11. Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)
12. Oncologie : ce qui a changé en 2022
13. A differential process mining analysis of COVID-19 management for cancer patients
14. Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events
15. Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
16. Delayed Diagnosis of Lung Carcinoma Presenting as Choroidal Metastasis in a COVID-19 Patient and Initially Treated with Osimertinib
17. Lung Stereotactic Radiation Therapy: Intercomparison of Several Irradiation Devices in Terms of Outcome and Predictive Factors
18. Thérapies ciblées et carcinomes non à petites cellules : nouveautés
19. Oncologie
20. Is sleeve lobectomy safe after induction therapy?—a systematic review and meta-analysis
21. BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer
22. Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor–Related Cholangiohepatitis
23. Early discharge after thoracoscopic anatomical pulmonary resection for non-small-cell lung cancer
24. Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data
25. Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data (Preprint)
26. Abscopal effect in a patient with malignant pleural mesothelioma treated with palliative radiotherapy and pembrolizumab
27. Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study
28. Oncologie
29. Suivi téléphonique des patients testés positifs au SARS-CoV-2 au Département d’oncologie du CHUV
30. Stereotactic Lung Reirradiation for Local Relapse: A Case Series
31. Long-lasting, irreversible and late-onset immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICIs): A real-world data analysis.
32. Curative management of a cardiac metastasis from lung cancer revealed by an electrical storm
33. Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study
34. Cancer du poumon à petites cellules : prise en charge et nouveautés
35. First-line treatment of ALK-positive NSCLC
36. Pembrolizumab as Palliative Immunotherapy in Malignant Pleural Mesothelioma
37. Oncologie
38. Nouvelles options thérapeutiques du cancer pulmonaire à l’ère de l’immunothérapie
39. Immunotherapy: A new standard of care in thoracic malignancies?
40. Immunotherapy: a new standard of care in thoracic malignancies?
41. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients
42. Nodules pulmonaires subsolides
43. Retreatment with nivolumab and ipilimumab with or without chemotherapy in patients with metastatic non-small cell lung cancer after progression on immune checkpoint inhibitor therapy.
44. Pulmonary Sarcoid–like Granulomatosis after Multiple Vaccinations of a Long-term Surviving Patient with Metastatic Melanoma
45. Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patient
46. La radiothérapie postopératoire a-t-elle une place dans le cancer pulmonaire ?
47. Definitive Organ-Sparing Treatment of Anal Canal Cancer: Can We Afford to Question It?
48. [b]Mélanome[/b] : une nouvelle ère thérapeutique
49. BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung Cancer.
50. A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.